FDA Prepares To Issue Draft Biomarker Qualifications Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA will issue draft guidance on qualifying biomarkers for use in drug development studies within the next few months, according to Commissioner Margaret Hamburg
You may also be interested in...
FDA Plans Guidance This Year On Co-Development Of Diagnostics And Drugs
FDA expects to complete a guidance document on co-development of diagnostics and drugs used for personalized medicine by the end of this year, FDA Commissioner Margaret Hamburg said at a meeting in Washington, D.C., Feb. 25
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.